CJC-1295 With DAC vs Without DAC
A comparison of the two CJC-1295 forms, focusing on the single chemical modification that changes how long the peptide persists in research systems.
Read articleA comparison of three compounds frequently studied in tissue models, how their research backgrounds differ, and why they are often examined together.
Three compounds dominate tissue-repair research protocols in Australia - BPC-157, TB-500, and GHK-Cu. Here is how their mechanisms differ and why researchers often study them together.
Tissue-repair research is one of the most active areas of peptide study in Australia, and three compounds account for most of it: BPC-157, TB-500, and GHK-Cu. Each is studied through a distinct mechanism, which is exactly why researchers frequently study them together rather than treating them as interchangeable options.
For the standalone research vial, view BPC-157 10mg : current price, availability and batch documentation. Research Use Only.
BPC-157 has been studied in laboratory models involving fibroblast signalling, nitric oxide pathways and growth-factor receptor expression. This section concerns BPC-157 alone. Wolverine Stack refers here to the BPC-157 + TB-500 combination, listed separately as 10mg and 20mg total-blend research vials. Studies of either ingredient do not establish the behaviour of the finished blend. Research Use Only.
In stock · same-business-day Australian dispatch
99.600% purity · batch JUNE-2026-198492 · tested 2026-07-25
TB-500 has been studied in preclinical models for flexibility, muscle recovery, and tissue healing, often examined alongside BPC-157 as a comparative pair in recovery and mobility research. Where BPC-157 works through signalling cascades, TB-500 (Thymosin Beta-4) acts directly on the cytoskeleton via actin sequestration - a distinct, non-overlapping mechanism that is exactly why the two are frequently paired in the same research design.
99.959% purity · batch CP-TB500-06-04 · tested 2026-07-25
GHK-Cu has been studied for its role in skin research, collagen production, and antioxidant gene-expression pathways, and features in dermal and hair-health research literature examining tissue remodelling and skin firmness. As a copper-coordinated tripeptide, its mechanism sits apart from both BPC-157 and TB-500 - it works through gene-expression and extracellular-matrix signalling rather than cascade or cytoskeletal pathways, which is why researchers studying tissue remodelling broadly often include it alongside the other two.
Availability is being updated; check the product page.
99.815% purity · batch 2026-210952 · tested 2026-07-31
The three compounds act through genuinely distinct, non-overlapping mechanisms - signalling cascade, cytoskeletal, and gene-expression - which makes a combined research design able to observe tissue repair from three separate angles at once rather than three attempts at the same one. This is the exact logic behind 's Muscle & Tissue Repair Kit , which bundles all three compounds together with a 10% research-kit discount and a batch-specific COA for each vial.
See the full Australian supplier checklist for the complete verification method.
BPC-157, TB-500, and GHK-Cu are supplied by exclusively as Research Use Only material for in vitro laboratory and analytical research. None are listed on the Australian Register of Therapeutic Goods (ARTG), approved for human or animal use, or intended for therapeutic application. does not provide dosing or administration guidance for any compound.
This compound is supplied for in vitro laboratory and educational research only. It is not listed on the Australian Register of Therapeutic Goods (ARTG) and is not a therapeutic good under the Therapeutic Goods Act 1989 (Cth). Not for human or animal consumption, therapeutic use, or diagnostic procedures. By purchasing, you confirm you are a qualified researcher or acting on behalf of a licensed research facility, and you assume full responsibility for the safe handling, storage, and lawful use of this compound.

A comparison of the two CJC-1295 forms, focusing on the single chemical modification that changes how long the peptide persists in research systems.
Read article
How Tesamorelin is positioned as a stabilised GHRH analogue and why it is used as a reference point in growth-hormone research.
Read article
A closer look at how Ipamorelin and CJC-1295 act on different receptors and timescales within the growth-hormone system.
Read article
How a peptide acting at three metabolic receptors differs from single- and dual-receptor designs in research models.
Read articleTell us what you need. An email address is required so we can reply.